Repare Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Repare Therapeutics
RPTX Stock  USD 2.57  0.03  1.15%   
Repare Therapeutics' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Repare Therapeutics' valuation are provided below:
Gross Profit
47.9 M
Market Capitalization
110.8 M
Enterprise Value Revenue
0.0201
Revenue
11.9 M
Earnings Share
(1.70)
We have found one hundred twenty available trending fundamental ratios for Repare Therapeutics, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to check out all of Repare Therapeutics recent market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. Market Cap is likely to drop to about 60.7 M in 2026. Enterprise Value is likely to rise to about (29.7 M) in 2026

Repare Therapeutics Total Revenue

33.57 Million

Check Repare Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Repare Therapeutics' main balance sheet or income statement drivers, such as Tax Provision of 2.6 M, Interest Income of 12.5 M or Depreciation And Amortization of 1.3 M, as well as many indicators such as Price To Sales Ratio of 1.14, Dividend Yield of 0.0 or PTB Ratio of 0.23. Repare financial statements analysis is a perfect complement when working with Repare Therapeutics Valuation or Volatility modules.
  
Build AI portfolio with Repare Stock
Check out the analysis of Repare Therapeutics Correlation against competitors.
For more information on how to buy Repare Stock please use our How to Invest in Repare Therapeutics guide.

Repare Therapeutics Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding37 M48.8 M27.4 M
Slightly volatile
Total Assets257.2 M203 M129.9 M
Slightly volatile
Short and Long Term Debt Total4 M2.2 M3 M
Slightly volatile
Other Current Liabilities14.5 M22.8 M7.9 M
Slightly volatile
Total Current Liabilities30.7 M29.1 M15.9 M
Slightly volatile
Other Liabilities2.9 M3.1 M6.9 M
Pretty Stable
Property Plant And Equipment Net7.6 M4.9 M4.3 M
Slightly volatile
Accounts Payable2.3 M4.2 M1.8 M
Slightly volatile
Cash176.3 M97.4 M87.1 M
Slightly volatile
Non Current Assets Total9.4 M6.2 M5.3 M
Slightly volatile
Non Currrent Assets Other1.4 M1.3 M364.3 K
Slightly volatile
Other Assets543 K571.5 K673.4 K
Slightly volatile
Cash And Short Term Investments235.9 M175.7 M117.6 M
Slightly volatile
Net Receivables7.1 M14.2 M4.4 M
Slightly volatile
Common Stock Total Equity580.4 M552.8 M202.4 M
Slightly volatile
Liabilities And Stockholders Equity257.2 M203 M129.9 M
Slightly volatile
Non Current Liabilities Total75.2 K79.2 K25.4 M
Slightly volatile
Capital Surpluse21.7 M20.7 M7.5 M
Slightly volatile
Other Current Assets4.8 M6.9 M2.6 M
Slightly volatile
Total Liabilities55.2 M29.2 M42.7 M
Slightly volatile
Property Plant And Equipment Gross10.2 M15.4 M6.1 M
Slightly volatile
Total Current Assets247.9 M196.8 M124.6 M
Slightly volatile
Capital Stock364.1 M559.7 M190.6 M
Slightly volatile
Non Current Liabilities Other39.2 M52 M24.3 M
Slightly volatile
Net Working Capital217.2 M167.7 M108.7 M
Slightly volatile
Common Stock364.1 M559.7 M190.6 M
Slightly volatile
Property Plant Equipment6.4 M11 M4.6 M
Slightly volatile
Current Deferred Revenue17.3 M11.8 M7.7 M
Slightly volatile
Short Term Debt1.7 M2.1 M1.1 M
Slightly volatile
Short Term Investments83.6 M78.3 M36.3 M
Slightly volatile

Repare Therapeutics Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Income12.5 M11.9 M4.1 M
Slightly volatile
Depreciation And Amortization1.3 M2.2 M820.7 K
Slightly volatile
Selling General Administrative20.2 M34.1 M12.5 M
Slightly volatile
Other Operating Expenses93.7 M169.1 M58.1 M
Slightly volatile
Research Development73.9 M134.4 M45.7 M
Slightly volatile
Cost Of Revenue14.6 M15.4 M17.8 M
Slightly volatile
Total Operating Expenses161.3 M153.7 M45.2 M
Slightly volatile
Reconciled Depreciation1.3 M2.2 M793 K
Slightly volatile
Net Interest Income6.5 M11.9 M3 M
Slightly volatile
Selling And Marketing Expenses1.9 M2.9 M1.6 M
Slightly volatile

Repare Therapeutics Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Sale Purchase Of Stock448.9 K472.5 K40.5 M
Very volatile
Net Borrowings1.2 M1.4 M1.5 M
Slightly volatile
Stock Based Compensation28 M26.6 M8.2 M
Slightly volatile
Begin Period Cash Flow146.2 M128 M79.1 M
Slightly volatile
Depreciation1.3 M2.2 M796.4 K
Slightly volatile
Total Cash From Financing Activities463.4 K487.8 K46.9 M
Very volatile
End Period Cash Flow157.7 M97.4 M92.5 M
Slightly volatile
Change To Netincome27.8 M26.4 M9 M
Slightly volatile
Change To Liabilities3.2 M3.3 M5 M
Pretty Stable
Cash And Cash Equivalents Changes6.9 M7.3 M152.9 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.141.196.1 K
Slightly volatile
Days Sales Outstanding92.0696.9110.8 K
Slightly volatile
Stock Based Compensation To Revenue0.470.512.3794
Slightly volatile
Capex To Depreciation1.091.146.0246
Slightly volatile
Payables Turnover3.163.3219.2746
Pretty Stable
Sales General And Administrative To Revenue0.610.6469.1232
Slightly volatile
Research And Ddevelopement To Revenue2.392.51198
Slightly volatile
Capex To Revenue0.04140.043610.7448
Slightly volatile
Cash Per Share4.43.243.032
Slightly volatile
Days Payables Outstanding108114663
Slightly volatile
Net Debt To EBITDA1.01.061.813
Slightly volatile
Current Ratio13.927.789.4601
Pretty Stable
Receivables Turnover6.493.93.0086
Slightly volatile
Capex Per Share0.0490.05290.0572
Slightly volatile
Revenue Per Share0.931.130.466
Slightly volatile
Interest Debt Per Share0.04980.05240.124
Slightly volatile
Debt To Assets0.0120.01260.1009
Slightly volatile
Operating Cycle92.0696.9110.8 K
Slightly volatile
Days Of Payables Outstanding108114663
Slightly volatile
Ebt Per Ebit1.091.021.1079
Slightly volatile
Quick Ratio13.927.789.4601
Pretty Stable
Net Income Per E B T0.910.921.0504
Pretty Stable
Cash Ratio3.663.857.5239
Very volatile
Days Of Sales Outstanding92.0696.9110.8 K
Slightly volatile
Fixed Asset Turnover11.9811.413.3727
Slightly volatile
Debt Ratio0.0120.01260.1009
Slightly volatile
Price Sales Ratio1.141.196.1 K
Slightly volatile
Asset Turnover0.140.270.0765
Slightly volatile

Repare Therapeutics Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap60.7 M63.9 M518.3 M
Pretty Stable

Repare Fundamental Market Drivers

Repare Upcoming Events

27th of February 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Repare Therapeutics Financial Statements

Repare Therapeutics investors use historical fundamental indicators, such as Repare Therapeutics' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Repare Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue11.8 M17.3 M
Total Revenue61.5 M33.6 M
Cost Of Revenue15.4 M14.6 M
Stock Based Compensation To Revenue 0.50  0.47 
Sales General And Administrative To Revenue 0.64  0.61 
Research And Ddevelopement To Revenue 2.51  2.39 
Capex To Revenue 0.04  0.04 
Revenue Per Share 1.13  0.93 
Ebit Per Revenue(1.57)(1.65)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
JBLJabil Circuit
MRKMerck Company
AMGNAmgen Inc

Additional Tools for Repare Stock Analysis

When running Repare Therapeutics' price analysis, check to measure Repare Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repare Therapeutics is operating at the current time. Most of Repare Therapeutics' value examination focuses on studying past and present price action to predict the probability of Repare Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repare Therapeutics' price. Additionally, you may evaluate how the addition of Repare Therapeutics to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY